This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →
VIOKACE
APTALIS PHARMA CANADA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of VIOKACE in Canada?
A shortage of VIOKACE 113400UNIT 112500UNIT 20880UNIT is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 30, 2026), but it has not started yet.
Why is VIOKACE not available?
The reason the manufacturer reported: Shortage of an active ingredient.
When will VIOKACE be available again?
The manufacturer's estimated resolution date is November 30, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02241933
Strength
113400UNIT 112500UNIT 20880UNIT
Dosage Form
TABLET
Route
ORAL
Active Ingredient
AMYLASE PROTEASE LIPASE
Tier
Unrated
Last Updated
2018-10-09
Reason for Shortage
Other (Please describe in comments)
Past Reports for This Drug
VIOKACE has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from APTALIS PHARMA CANADA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.